v.231201
Showing details for project SYSMHC00082
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
|---|---|---|---|---|---|
| SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
| SYSMHC00082_3497GA_HLADP | 2 | Human | HLA-DPA10103-DPB10201,HLA-DPA10103-DPB10402,HLA-DPA10103-DPB110501,HLA-DPA10103-DPB141601 | ||
| SYSMHC00082_3497GA_HLADQ | 2 | Human | HLA-DQA10101-DQB10501,HLA-DQA10103-DQB10603 | ||
| SYSMHC00082_3497GA_HLADR | 2 | Human | DRB1_0101,DRB1_1301,DRB3_0101 | ||
| SYSMHC00082_3497GA_HLAIIp | 2 | Human | DRB1_0101,DRB1_1301,DRB3_0101,HLA-DPA10103-DPB10201,HLA-DPA10103-DPB10402,HLA-DPA10103-DPB110501,HLA-DPA10103-DPB141601,HLA-DQA10101-DQB10501,HLA-DQA10103-DQB10603 | ||
| SYSMHC00082_3865DM | 4 | Human | DRB1_0101,DRB1_0701,DRB4_0103,HLA-DPA10103-DPB10401,HLA-DPA10103-DPB12001,HLA-DQA10101-DQB10303,HLA-DQA10201-DQB10501 | ||
| SYSMHC00082_4021_HLADP | 2 | Human | HLA-DPA10103-DPB10301,HLA-DPA10103-DPB110401 | ||
| SYSMHC00082_4021_HLADQ | 2 | Human | HLA-DQA10303-DQB10202,HLA-DQA10505-DQB10301 | ||
| SYSMHC00082_4021_HLADR | 2 | Human | DRB1_0405,DRB1_1101,DRB3_0202,DRB4_0103 | ||
| SYSMHC00082_4021_HLAIIp | 2 | Human | DRB1_0405,DRB1_1101,DRB3_0202,DRB4_0103,HLA-DQA10303-DQB10202,HLA-DQA10505-DQB10301,HLA-DPA10103-DPB10301,HLA-DPA10103-DPB110401 | ||
| SYSMHC00082_CM647 | 4 | Human | HLA-DPA10103-DPB10201,HLA-DPA10103-DPB12301,HLA-DQA10102-DQB10202,HLA-DQA10201-DQB10502,DRB1_0701,DRB1_1601,DRB4_0103,DRB5_0202 | ||
| SYSMHC00082_CTE-BIO-00151_HLADP | 2 | Human | HLA-DPA10103-DPB10201,HLA-DPA10103-DPB10402,HLA-DPA10103-DPB110501,HLA-DPA10103-DPB141601 | ||
| SYSMHC00082_CTE-BIO-00151_HLADQ | 2 | Human | HLA-DQA10101-DQB10501,HLA-DQA10103-DQB10603 | ||
| SYSMHC00082_CTE-BIO-00151_HLADR | 2 | Human | DRB1_0101,DRB1_1301,DRB3_0101 | ||
| SYSMHC00082_CTE-BIO-00151_HLAIIp | 2 | Human | DRB1_0101,DRB1_1301,DRB3_0101,HLA-DPA10103-DPB10201,HLA-DPA10103-DPB10402,HLA-DPA10103-DPB110501,HLA-DPA10103-DPB141601,HLA-DQA10101-DQB10501,HLA-DQA10103-DQB10603 | ||
| SYSMHC00082_JY | 4 | Human | DRB1_0404,DRB1_1301,DRB3_0101,DRB4_0103,HLA-DPA10103-DPB10201,HLA-DPA10103-DPB10401,HLA-DQA10103-DQB10302,HLA-DQA10301-DQB10603 | ||
| SYSMHC00082_RA957_HLADP | 2 | Human | HLA-DPA10103-DPB10401,HLA-DPA10103-DPB10402,HLA-DPA10103-DPB110501,HLA-DPA10103-DPB112601 | ||
| SYSMHC00082_RA957_HLADQ | 2 | Human | HLA-DQA10303-DQB10301,HLA-DQA10401-DQB10402 | ||
| SYSMHC00082_RA957_HLADR | 2 | Human | DRB1_0401,DRB1_0801,DRB4_0103 | ||
| SYSMHC00082_RA957_HLAIIp | 2 | Human | DRB1_0401,DRB1_0801,DRB4_0103,HLA-DPA10103-DPB10401,HLA-DPA10103-DPB10402,HLA-DPA10103-DPB110501,HLA-DPA10103-DPB112601,HLA-DQA10303-DQB10301,HLA-DQA10401-DQB10402 |
Detailed view of sample SYSMHC00082_3865DM
| ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
| SYSMHC00082 | SYSMHC00082_3865DM | 20190314_QE_HFX2_LC3_SA_JMI_3865DM_HLADP_R01.raw | Human | In vitro | Blood | RA | suspension | Epstein-Cbarr-virus-transformed | class II | DRB1_0101,DRB1_0701,DRB4_0103,HLA-DPA10103-DPB10401,HLA-DPA10103-DPB12001,HLA-DQA10101-DQB10303,HLA-DQA10201-DQB10501 | PXD034773 | native | Immunoaffinity | HB145 | Q-Exactive HF | no | DDA | HCD | 2-100%(0.1% FC in 80% ACN) | 90 | 250nl/min | 1 | ||
| SYSMHC00082 | SYSMHC00082_3865DM | 20190314_QE_HFX2_LC3_SA_JMI_3865DM_HLADQ_R01.raw | Human | In vitro | Blood | RA | suspension | Epstein-Cbarr-virus-transformed | class II | DRB1_0101,DRB1_0701,DRB4_0103,HLA-DPA10103-DPB10401,HLA-DPA10103-DPB12001,HLA-DQA10101-DQB10303,HLA-DQA10201-DQB10501 | PXD034773 | native | Immunoaffinity | HB145 | Q-Exactive HF | no | DDA | HCD | 2-100%(0.1% FC in 80% ACN) | 90 | 250nl/min | 2 | ||
| SYSMHC00082 | SYSMHC00082_3865DM | 20190314_QE_HFX2_LC3_SA_JMI_3865DM_HLADR_R01.raw | Human | In vitro | Blood | RA | suspension | Epstein-Cbarr-virus-transformed | class II | DRB1_0101,DRB1_0701,DRB4_0103,HLA-DPA10103-DPB10401,HLA-DPA10103-DPB12001,HLA-DQA10101-DQB10303,HLA-DQA10201-DQB10501 | PXD034773 | native | Immunoaffinity | HB145 | Q-Exactive HF | no | DDA | HCD | 2-100%(0.1% FC in 80% ACN) | 90 | 250nl/min | 3 | ||
| SYSMHC00082 | SYSMHC00082_3865DM | 20190314_QE_HFX2_LC3_SA_JMI_3865DM_HLAIIp_R01.raw | Human | In vitro | Blood | RA | suspension | Epstein-Cbarr-virus-transformed | class II | DRB1_0101,DRB1_0701,DRB4_0103,HLA-DPA10103-DPB10401,HLA-DPA10103-DPB12001,HLA-DQA10101-DQB10303,HLA-DQA10201-DQB10501 | PXD034773 | native | Immunoaffinity | HB145 | Q-Exactive HF | no | DDA | HCD | 2-100%(0.1% FC in 80% ACN) | 90 | 250nl/min | 4 |